NasdaqCM - Delayed Quote
USD
Talphera, Inc. (TLPH)
1.0300
-0.0400
(-3.74%)
At close: October 30 at 4:00:01 PM EDT
Loading chart for TLPH
- Previous Close
1.0700 - Open
1.0706 - Bid 1.0700 x 100
- Ask 1.0400 x 100
- Day's Range
1.0300 - 1.0800 - 52 Week Range
0.6900 - 1.5700 - Volume
83,504 - Avg. Volume
174,421 - Market Cap (intraday)
53.463M - Beta (5Y Monthly) 0.68
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2600 - Earnings Date (est.) Nov 11, 2026
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
3.12 - Motley Fool Rating Bearish
Recent News
View More
Performance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
TLPH
9.65%
S&P 500 (^GSPC)
10.73%
1-Year Return
TLPH
16.94%
S&P 500 (^GSPC)
11.11%
3-Year Return
TLPH
101.96%
S&P 500 (^GSPC)
81.91%
5-Year Return
TLPH
94.15%
S&P 500 (^GSPC)
64.59%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 10/30/2026
-
Market Cap
53.72M
-
Enterprise Value
36.65M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (current)
--
-
Price/Sales (ttm)
1.30k
-
Price/Book (mrq)
3.73
-
Enterprise Value/Revenue
36.65k
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-42.55%
-
Return on Equity (ttm)
-143.36%
-
Revenue (ttm)
1k
-
Net Income Avi to Common (ttm)
-15.08M
-
Diluted EPS (ttm)
-0.2600
Balance Sheet and Cash Flow
-
Total Cash (mrq)
17.08M
-
Total Debt/Equity (mrq)
45.11%
-
Levered Free Cash Flow (ttm)
-6.87M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
5.17
-4.44%
Mkt Cap
145.92M
Industry
Drug Manufacturers—Specialty & Generic
52.18
-2.78%
Mkt Cap
1.491B
Industry
Drug Manufacturers—Specialty & Generic
0.7065
-4.81%
Mkt Cap
195.776M
Industry
Drug Manufacturers—Specialty & Generic
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
23.50
0.00%
Mkt Cap
151.861M
Industry
Drug Manufacturers—Specialty & Generic
8.47
-0.59%
Mkt Cap
2.164B
Industry
Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
